Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer | Nature Communications
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin | PLOS ONE
With its liquid biopsy approval, Foundation Medicine takes on Guardant | Evaluate
FDA Approves Blood Tests That Can Help Guide Cancer Treatment - NCI
Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan | Business Wire
Latest Medical News
Foundation Medicine Introduces FoundationOne®Liquid, the Latest Advance in the Company's Liquid Biopsy Test for Solid Tumors in Patients with Advanced Cancer | Technology Networks
First Comprehensive Next-gen Sequencing based Pan-Tumor Liquid Biopsy Test Approved - Onco'Zine
Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy
Foundation Medicine wins FDA OK for pan-cancer liquid biopsy test
Foundation Medicine touts concordance ahead of FDA ruling on liquid biopsy test - MedCity News
Foundation Medicine to launch liquid biopsy companion diagnostic following FDA approval - MedCity News
FoundationOne Liquid
Multi-gene Testing (NGS) for PIK3CA Mutations
Foundation Medicine receives FDA approval for pan-tumour biopsy test
Foundation Medicine Eyes Liquid Biopsy Expansion, DNA Methylation Adoption, with Lexent Bio Acquisition | Inside Precision Medicine
See more, do more
Latest Medical News
Comprehensive genomic profiling in oncology – from vision to reality | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
FoundationOne®CDx Technical Information Foundation Medicine, Inc. 150 Second Street, Cambridge, MA 02141 Phone: 617.418.2200 I
Foundation Medicine Liquid Biopsy Gets FDA Okay – ISPE Boston
Foundation Medicine Announces Commercial Launch of Solid Tumor Liquid Biopsy
Foundation Medicine on LinkedIn: Join Foundation Medicine's Lucas Dennis, VP of Franchise Development, for…
Compare Our Tests | Foundation Medicine
Axial - Foundation Medicine - by Joshua Elkington - Axial
